New Frontiers in Oncology: Advanced Diagnostics and Therapeutics
By
Springer Healthcare IME
FEATURING
Solange Peters
By
Springer Healthcare IME
FEATURING
Solange Peters
Explore the new frontiers in oncology with a focus on advanced diagnostics and therapeutics. In this video, Dr. Solange Peters discusses the latest advancements in molecular profiling, the importance of broad molecular analysis for actionable oncogenic drivers, and the critical impact of biomarker testing on patient outcomes. Stay informed about the integration of cutting-edge diagnostic technologies and the future of cancer treatment.
Key Topics:
• Advanced molecular profiling techniques
• Actionable oncogenic drivers in cancer
• Impact of biomarker testing on treatment outcomes
Access a downloadable transcript of this webinar at https://targeted-therapies-lung-cancer.ime.springerhealthcare.com/#chapter3
This is episode #3 of 4, and is part is part of an ACCME- and EACCME-accredited, Independent Medical Education program entitled, Biomarker-Positive Disease: A Personalized Approach to Selecting Targeted Therapies in Lung Cancer and Beyond.
To learn more about the full program or to CLAIM YOUR CREDITS, visit https://targeted-therapies-lung-cancer.ime.springerhealthcare.com/
---
This activity is supported by independent educational grants from Roche and Illumina.
Key Topics:
• Advanced molecular profiling techniques
• Actionable oncogenic drivers in cancer
• Impact of biomarker testing on treatment outcomes
Access a downloadable transcript of this webinar at https://targeted-therapies-lung-cancer.ime.springerhealthcare.com/#chapter3
This is episode #3 of 4, and is part is part of an ACCME- and EACCME-accredited, Independent Medical Education program entitled, Biomarker-Positive Disease: A Personalized Approach to Selecting Targeted Therapies in Lung Cancer and Beyond.
To learn more about the full program or to CLAIM YOUR CREDITS, visit https://targeted-therapies-lung-cancer.ime.springerhealthcare.com/
---
This activity is supported by independent educational grants from Roche and Illumina.
Comments 0
Login to view comments.
Click here to Login
